124I-huA33

N/A

Report date: 2025/10/20 14:38:42

Base Information

Drug Name124I-huA33
Drug Alias Name124I-huA33
ClassificationRadiation-emitting products > Nuclides > Iodine > 124IRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionCell surface A33 antigen inhibitors
TargetsCell surface A33 antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer CenterLudwig Institute For Cancer Research
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A